Gabriel Wolski
Defective Drug Recalls Lawyer
Education
MITCHELL HAMLINE SCHOOL OF LAW,
Juris Doctor
GOUCHER COLLEGE,
Bachelor’s Degree
Associations
- Minnesota State Bar Association
Bar Admissions
- Minnesota State Court
- Federal Court – District of Minnesota
- Federal Court – District of Wisconsin
- Federal Court – District of Western Texas
Eugene Sherayzen, Esq.
Defective Drug Recalls Lawyer
Eugene Sherayzen is the founder and owner of Sherayzen Law Office, PLLC. Since 2005, Mr. Sherayzen has helped hundreds of individuals and companies to solve their personal and business problems related to US and International Tax Compliance, Offshore Voluntary Disclosures, and International Tax & Estate Planning.
Mr. Sherayzen primarily practices in the areas of U.S. and international business and tax law. His main areas of concentration include International Tax Compliance, Offshore Voluntary Disclosures and International Tax & Estate Planning.
Mr. Sherayzen is highly experienced in such complex areas as: IRS OVDP (Offshore Voluntary Disclosure Program) with its new offshoots of Streamlined Domestic Offshore Procedures and Streamlined Foreign Offshore Procedures, FATCA (Foreign Account Tax Compliance Act), FBARs (Report on Foreign Bank and Financial Accounts – Form TD F 90-22.1), PFICs (Passive Foreign Investment Company – Form 8621), FDE (Foreign Disregarded Entity – Form 8858), U.S. Ownership of Foreign Partnerships (Form 8865), U.S. Ownership of Foreign Corporations (Form 5471), Foreign Ownership of U.S. Corporations (Form 5472), and other related forms and regulations.
Joe Tamburino
Defective Drug Recalls Lawyer
Joe Tamburino is one of the most effective criminal defense attorneys in the Twin Cities and has been named a Minnesota “Super Lawyer” for the last two decades straight. His passion for excellence in criminal defense has led to an exclusive rating as a Minnesota State Bar Association Board Certified Legal Specialist in Criminal Law, he is 1 of 50 attorneys in the state.
A graduate of New York University and the University of Minnesota Law School, Tamburino began his career in the Anoka County Attorney’s Office and then the Public Defender’s Office. In 1997, he joined what would become Tamburino Law Group and has become a prominent and visible member of the Minnesota legal community. Early in his career, Tamburino was named a Rising Star in Minnesota by Minnesota Law & Politics. Minnesota Lawyer has ranked him a Super Lawyer for the last two decades. In 2023, Joe Tamburino was given the Minnesota Icon Award by Minnesota Finance & Commerce Magazine for lifetime career achievement and contributions to the community.
Ronald Meshbesher
Defective Drug Recalls Lawyer
Ron Meshbesher, one of the most well-known and well-respected lawyers in Minnesota, was the founder of Meshbesher & Spence. His unique experience in both civil and criminal courts was unparalleled. He began practicing law at the age of 24 in the Hennepin County Attorney’s Office as a prosecutor, where he tried 45 felony cases in his first three years with a 92% conviction rate. He founded this private practice in 1961, and continued his track record of success throughout his 50-year career at Meshbesher & Spence.
Ron earned his stellar national reputation as counsel in many highly publicized criminal defense cases in Minnesota criminal courts in the 1970’s and 1980’s, including the Elizabeth Congdon murder case, the Piper kidnapping case (which still remains the largest unsolved kidnapping case on FBI record), the Dave Forbes hockey assault trial, and countless others. All of these cases resulted in acquittals, or in the case of Forbes, a hung jury.
Ron’s accomplishments in the civil courtroom were equally impressive. He tried all types of civil cases, including personal injury, will contests, copyright infringement, medical and legal malpractice, and class action, setting multiple state records for the settlements and verdicts he won for his clients.
Ryan P. Garry
Defective Drug Recalls Lawyer
Top rated criminal defense attorney Ryan Garry is a Criminal Law Specialist, certified by the the Minnesota State Bar Association, and has developed a reputation as an accomplished trial attorney. Less than 3% of criminal defense attorneys in Minnesota have achieved this certification. Our law practice represents individuals and businesses dealing with accusations and criminal charges brought by the state and federal government.
Nearly 100% of Ryan’s practice since inception has been representing clients on cases ranging from DWI to Murder to major White Collar Crime. He has acquitted clients with not-guilty verdicts, orders to dismiss, hung juries, and declination of prosecution in cases ranging from DWI to Murder. His most recent cases include acquittals and not guilty verdicts include Felony Third Degree Assault, Felony First Degree Assault, Felony Domestic Assault Strangulation, and Aiding First Degree Murder and Controlled Substance in the First Degree.
Maxwell Shek
Defective Drug Recalls Lawyer
- University of Minnesota Law School, Minneapolis, Minnesota
- J.D.
- Honors: Dean’s List
- University of Minnesota, Carlson School of Business
- M.B.A.
- Honors: Dean’s List
- Michigan State University, B.S.
- Honors: With honors
- Bar Admission: Minnesota
I completed my undergraduate from Michigan State University, where I graduated with honors. I then earned my Juris Doctor’s degree from The University of Minnesota Law School and received a master’s in business administration from The University of Minnesota, Carlson School of Business. These JD and MBA programs are each nationally ranked and are the highest-ranked programs in Minnesota.
From there, I entered the world of banking regulation, where I worked for one of the largest financial institutions in the United States. I became deeply familiar with strict protocols and analyzing complex processes to ensure there were no missed details. Though I loved my role, I wanted to do more to help others, which was my motivator to open Shek Law. As a dedicated attorney, I have an extensive understanding of Minnesota laws, and I am devoted to delivering exceptional legal counseling and representation that positions my clients to obtain the vigorous defense they deserve.
Robert J. Hoglund
Defective Drug Recalls Lawyer
He has since garnered recognition from top law firms throughout the nation. He is a proud owner and CEO of a firm that provides not only his clients with satisfaction but also over 200 employees with a stable and rewarding work life. Robert attributes his success to his continuous foresight and ability to pinpoint advantageous opportunities.
When Robert is not in the office, he spends his time with his family participating in various outdoor activities, including gardening, hunting, and snowmobiling.
What drugs have been recalled recently?
Drug recalls are common measures taken to protect public health, often following quality, contamination, or safety concerns. Here’s a summary of major drug recalls from recent months, especially as of July 2025:
Noteworthy Drug Recalls (March–July 2025)
| Drug/Product Name | Manufacturer/Distributor | Reason for Recall | Recall Date |
|---|---|---|---|
| Levetiracetam in Sodium Chloride Injection | Dr. Reddy’s | Mislabeling of infusion bag | March 13, 2025 |
| Sucralfate Tablets USP 1g | Nostrum Laboratories | Company closure and discontinuation of quality | Early 2025 |
| Cefazolin for Injection, USP 1g | Sandoz | Potential presence of Penicillin G contamination | Early 2025 |
| Sulfamethoxazole/Trimethoprim Tablets | Amneal Pharmaceutical | Microbial contamination | June 2, 2025 |
| Chlorpromazine Hydrochloride Tablets 10mg | Zydus Pharmaceuticals | Carcinogenic impurity (Nitrosamines/NDSRIS) | April 3, 2025 |
| Propafenone Hydrochloride ER Capsules | Glenmark Pharmaceuticals | cGMP manufacturing deviations | March 13, 2025 |
| Solifenacin Succinate Tablets | Glenmark Pharmaceuticals | cGMP manufacturing deviations | March 13, 2025 |
| Gabapentin Capsules | Sun Pharma | Cross-contamination concerns | 2025 |
| Carvedilol Tablets (3.125 & 6.25mg) | Glenmark Pharmaceuticals | Impurity: N-Nitroso Carvedilol I above limits | June 4, 2025 |
| Testosterone 25mg (1%) | Strides Pharma | Presence of benzene (toxic impurity) | April 2, 2025 |
| Metoclopramide Tablets USP 10mg | Teva Pharmaceuticals | Presence of Torsemide Tablets in bottles | May 23, 2025 |
| Potassium Chloride Injection bags | ICU Medical | Mislabeling | February 13, 2025 |
| Fentanyl Transdermal System 25 mcg/h | Alvogen | Defective delivery system | January 31, 2025 |
| Lisdexamfetamine Dimesylate (ADHD drug) | Sun Pharma | Manufacturing issue | July 24, 2025 |
| Mercaptopurine 50mg tablets | Aspen Pharma (UK/EU) | Non-disclosed safety issue | May 22, 2025 |
| Various over-the-counter acetaminophen, ibuprofen, cetirizine hydrochloride (sold at major retailers) | Glenmark | Manufacturing and quality control deviations | April 2025 |
Additional Details
Microbial Contamination: Multiple recalls involved the presence of harmful bacteria or particulates, which could cause infections or other adverse reactions.
Impurity Risks: Notably, several recalls were initiated for drugs with detectable levels of nitrosamines or benzene, both recognized as potential carcinogens.
Mix-up/Label Issues: Incidents where medications were mislabeled or mixed with incorrect tablets (e.g., metoclopramide contaminated with torsemide) present direct safety threats.
Quality Control Deviations: Many recalls stemmed from lapses in manufacturing practices, such as inadequate facility conditions, equipment failures, or improper quality checks.
What to Do If Your Drug Is Recalled
Stop Using: If your medication has been recalled, discontinue use and contact your pharmacy or healthcare provider for guidance.
Check Lot Numbers: Always verify the lot number and expiration date on your medication against recall lists issued by the FDA, manufacturers, or your national regulatory agency.
Report Issues: Adverse reactions or product complaints should be reported to regulatory authorities (e.g., FDA’s MedWatch program).
Key Takeaway
A wide range of both prescription and over-the-counter drugs has been recalled in 2025 for reasons spanning contamination, impurities, and labeling errors. Vigilance and prompt response to recall alerts are essential for patient safety.